Literature DB >> 25387724

Immunological effects and therapeutic role of C5a in cancer.

Victoria R Darling1, Ralph J Hauke, Stefano Tarantolo, Devendra K Agrawal.   

Abstract

The specific role of C5a in cancer, especially in melanoma, has yet to be determined. Differential effects of C5a could be cancer specific. In the host defense system, C5a functions to protect the body from harmful entities via a plethora of mechanisms. Yet, C5a may also serve to potentiate cancerous process. C5a facilitates cellular proliferation and regeneration by attracting myeloid-derived suppressor cells and supporting tumor promotion. In this article, we critically reviewed the properties, mechanisms of action and functions of C5a, with particular emphasis on cancer inhibition and promotion, and clinical application of such knowledge in better management of patients with cancer. Outstanding questions and future directions in regard to the function of C5a in melanoma and other cancers are discussed.

Entities:  

Keywords:  C5a; cancer; chronic inflammation; complement; immunosuppression; melanoma

Mesh:

Substances:

Year:  2014        PMID: 25387724      PMCID: PMC4637164          DOI: 10.1586/1744666X.2015.983081

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  71 in total

1.  Molecular analysis of human complement component C5: localization of the structural gene to chromosome 9.

Authors:  R A Wetsel; R S Lemons; M M Le Beau; S R Barnum; D Noack; B F Tack
Journal:  Biochemistry       Date:  1988-03-08       Impact factor: 3.162

Review 2.  The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions.

Authors:  Ron N Apte; Shahar Dotan; Moshe Elkabets; Malka R White; Eli Reich; Yaron Carmi; Xiaping Song; Tatyana Dvozkin; Yakov Krelin; Elena Voronov
Journal:  Cancer Metastasis Rev       Date:  2006-09       Impact factor: 9.264

Review 3.  Role of C5a in inflammatory responses.

Authors:  Ren-Feng Guo; Peter A Ward
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

4.  The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis.

Authors:  M D Sternlicht; A Lochter; C J Sympson; B Huey; J P Rougier; J W Gray; D Pinkel; M J Bissell; Z Werb
Journal:  Cell       Date:  1999-07-23       Impact factor: 41.582

5.  Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself.

Authors:  R Schindler; J A Gelfand; C A Dinarello
Journal:  Blood       Date:  1990-10-15       Impact factor: 22.113

6.  C5a, but not C3a, increases VEGF secretion in ARPE-19 human retinal pigment epithelial cells.

Authors:  Daniel N Cortright; Robin Meade; Stephen M Waters; Bertrand L Chenard; James E Krause
Journal:  Curr Eye Res       Date:  2009-01       Impact factor: 2.424

7.  Novel C5a agonist-based dendritic cell vaccine in a murine model of melanoma.

Authors:  Anthony A Floreani; Sandra J Gunselman; Arthur J Heires; Ralph J Hauke; Stefano Tarantolo; John D Jackson
Journal:  Cell Cycle       Date:  2007-08-15       Impact factor: 4.534

8.  Cancer and complement.

Authors:  Suzanne Ostrand-Rosenberg
Journal:  Nat Biotechnol       Date:  2008-12       Impact factor: 54.908

9.  Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.

Authors:  L E Benjamin; D Golijanin; A Itin; D Pode; E Keshet
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.

Authors:  M Clauss; M Gerlach; H Gerlach; J Brett; F Wang; P C Familletti; Y C Pan; J V Olander; D T Connolly; D Stern
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

View more
  9 in total

1.  C5aR1 regulates migration of suppressive myeloid cells required for costimulatory blockade-induced murine allograft survival.

Authors:  Ines Llaudo; Miguel Fribourg; M Edward Medof; Patricia Conde; Jordi Ochando; Peter S Heeger
Journal:  Am J Transplant       Date:  2018-09-17       Impact factor: 8.086

2.  Exosome secretome and mediated signaling in breast cancer patients with nontuberculous mycobacterial disease.

Authors:  Julie V Philley; Anbarasu Kannan; David E Griffith; Megan S Devine; Jeana L Benwill; Richard J Wallace; Barbara A Brown-Elliott; Foram Thakkar; Varsha Taskar; James G Fox; Ammar Alqaid; Hernaina Bains; Sudeep Gupta; Santanu Dasgupta
Journal:  Oncotarget       Date:  2017-03-14

3.  Super Secondary Structures of Proteins with Post-Translational Modifications in Colon Cancer.

Authors:  Dmitry Tikhonov; Liudmila Kulikova; Arthur Kopylov; Kristina Malsagova; Alexander Stepanov; Vladimir Rudnev; Anna Kaysheva
Journal:  Molecules       Date:  2020-07-09       Impact factor: 4.411

Review 4.  The role of complement in the tumor microenvironment.

Authors:  Danyaal Ain; Talha Shaikh; Samantha Manimala; Berhane Ghebrehiwet
Journal:  Fac Rev       Date:  2021-11-29

Review 5.  Advances in Immune Microenvironment and Immunotherapy of Isocitrate Dehydrogenase Mutated Glioma.

Authors:  Dongming Yan; Weicheng Li; Qibing Liu; Kun Yang
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

6.  Macrophages expedite cell proliferation of prostate intraepithelial neoplasia through their downstream target ERK.

Authors:  Mikalah U Thomas; Justin K Messex; Tu Dang; Sarki A Abdulkadir; Cheryl L Jorcyk; Geou-Yarh Liou
Journal:  FEBS J       Date:  2020-09-25       Impact factor: 5.542

Review 7.  S100 Soil Sensor Receptors and Molecular Targeting Therapy Against Them in Cancer Metastasis.

Authors:  Nahoko Tomonobu; Rie Kinoshita; Masakiyo Sakaguchi
Journal:  Transl Oncol       Date:  2020-03-17       Impact factor: 4.243

Review 8.  Potential Role of Myeloid-Derived Suppressor Cells (MDSCs) in Age-Related Macular Degeneration (AMD).

Authors:  Anu Kauppinen; Kai Kaarniranta; Antero Salminen
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561

Review 9.  Inflammation markers in cutaneous melanoma - edgy biomarkers for prognosis.

Authors:  Monica Neagu; Carolina Constantin; Georgiana Roxana Dumitrascu; Andreea Roxana Lupu; Constantin Caruntu; Daniel Boda; Sabina Zurac
Journal:  Discoveries (Craiova)       Date:  2015-03-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.